Genelux Corporation Common Stock (GNLX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $84.38M
Last updated: Nov 17, 2026 at 11:05 AM ET
Genelux Corporation Common Stock (GNLX) Earnings: Report Dates and Results
In the quarter ended Sep 30, 2026, Genelux Corporation Common Stock reported EPS of -$0.21, below the -$0.20 estimate. It beat the EPS estimate in 3 of the last 8 quarters.
Earnings
Performance (10Y)
Upcoming Estimates
Next Report
GNLX's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.
Earnings History
Of the 15 quarters below that had an estimate, GNLX beat 3, missed 9 and matched 3. The widest gap in the table came in the quarter ended Mar 31, 2023, when EPS landed 231.25% below the estimate.
| Quarter ended | EPS | Estimate | Range | Surprise | Result | YoY | Analysts | Revisions | Reported | Revenue |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 30, 2026 | -$0.21 | -$0.20 | -$0.22 - -$0.18 | -5.00% | Miss | N/A | 6 | 2 up, 1 down | Nov 11, 2026 | N/A |
| Jun 30, 2026 | -$0.21 | -$0.20 | -$0.22 - -$0.18 | -5.00% | Miss | N/A | 6 | 2 up, 1 down | Aug 13, 2026 | N/A |
| Mar 31, 2026 | -$0.20 | -$0.20 | -$0.26 - -$0.18 | 0.00% | In line | N/A | 5 | 2 up, 0 down | May 7, 2026 | N/A |
| Dec 31, 2025 | -$0.24 | -$0.22 | -$0.25 - -$0.20 | -9.94% | Miss | N/A | 6 | N/A | Mar 19, 2026 | $8000 |
| Sep 30, 2025 | -$0.21 | -$0.23 | -$0.24 - -$0.20 | +8.70% | Beat | N/A | 5 | 3 up, 0 down | Nov 5, 2025 | N/A |
| Jun 30, 2025 | -$0.20 | -$0.22 | -$0.24 - -$0.20 | +9.09% | Beat | N/A | 5 | 1 up, 0 down | Aug 7, 2025 | N/A |
| Mar 31, 2025 | -$0.21 | -$0.24 | -$0.30 - -$0.19 | +12.50% | Beat | N/A | 4 | 0 up, 2 down | May 6, 2025 | N/A |
| Dec 31, 2024 | -$0.25 | -$0.25 | N/A | 0.00% | In line | N/A | 4 | 1 up, 0 down | Mar 28, 2025 | $896000 |
| Sep 30, 2024 | -$0.19 | -$0.19 | -$0.21 - -$0.17 | 0.00% | In line | N/A | 4 | 1 up, 0 down | Nov 14, 2024 | N/A |
| Jun 30, 2024 | -$0.22 | -$0.21 | -$0.26 - -$0.12 | -4.76% | Miss | N/A | 3 | 0 up, 0 down | Aug 14, 2024 | N/A |
| Mar 31, 2024 | -$0.29 | -$0.21 | -$0.26 - -$0.21 | -38.10% | Miss | N/A | 2 | 0 up, 0 down | May 9, 2024 | $8000 |
| Dec 31, 2023 | -$0.25 | -$0.19 | -$0.22 - -$0.13 | -31.58% | Miss | N/A | 4 | 0 up, 0 down | Mar 29, 2024 | $1.46M |
| Sep 30, 2023 | -$0.20 | -$0.15 | -$0.22 - -$0.12 | -33.33% | Miss | N/A | 3 | 0 up, 0 down | Nov 14, 2023 | N/A |
| Jun 30, 2023 | -$0.23 | -$0.15 | -$0.19 - -$0.12 | -53.33% | Miss | N/A | 2 | 0 up, 0 down | Aug 14, 2023 | N/A |
| Mar 31, 2023 | -$0.53 | -$0.16 | -$0.16 - -$0.16 | -231.25% | Miss | N/A | 1 | 0 up, 0 down | May 15, 2023 | $170000 |
| Dec 31, 2022 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jan 26, 2023 | $68000 |
| Jun 30, 2022 | -$0.12 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Sep 19, 2022 | N/A |
| Mar 31, 2022 | -$0.16 | N/A | N/A | N/A | N/A | N/A | N/A | N/A | Jun 29, 2022 | N/A |
Annual EPS
EPS for the fiscal year ended Dec 31, 2025 was -$0.86, after -$0.95 the year before. It was -$0.40 for the year ended Dec 31, 2022, the oldest of the 4 fiscal years shown.
| Fiscal year ended | EPS | Change |
|---|---|---|
| Dec 31, 2025 | -$0.86 | N/A |
| Dec 31, 2024 | -$0.95 | N/A |
| Dec 31, 2023 | -$1.21 | N/A |
| Dec 31, 2022 | -$0.40 | N/A |
Frequently Asked Questions About GNLX
Did GNLX beat earnings estimates last quarter?
No. Genelux Corporation Common Stock reported EPS of -$0.21 for the quarter ended Sep 30, 2026, below the -$0.20 estimate by 5.00%.
What EPS do analysts expect from GNLX next quarter?
The consensus EPS estimate for Genelux Corporation Common Stock for the quarter ending Dec 31, 2026 is -$0.20 from 7 analysts, with estimates from -$0.23 to -$0.18.
How often does GNLX beat earnings estimates?
Genelux Corporation Common Stock beat the EPS estimate in 3 of the last 8 quarters, with an average surprise of +1.29%.
GNLX pages: Overview, Earnings, Forecast, Financials, Competitors